glp 1 and intracranial hypertension Treatment with GLP-1 receptor agonists is associated with significant weight loss favorable headache outcomes in idiopathic | The Journal of Headache and Pain Glucagon-like peptide-1 medicines in neurological

And yes, as mentioned, its completely non-synthetic

For patients with type 2 diabetes using semaglutide, there is a caution regarding diabetic retinopathy complications, particularly if rapid improvement in glucose control occurs

IGF Binding Proteins and Bioavailability The mechanism underlying this enhanced potency relates to IGF-1's complex regulatory system involving IGF binding proteins (IGFBPs), a family of six high-affinity binding proteins (IGFBP-1 through IGFBP-6) that normally sequester the vast majority of circulating IGF-1 and regulate its bioavailability, half-life, and access to cell surface IGF-1 receptors

The DNA damaging revolution: PARP inhibitors and beyond

Chong HX, Yusoff NAA, Hor YY, Lew LC, Jaafar MH, Choi SB, Yusoff MSB, Wahid N, Abdullah MFIL, Zakaria N, Ong KL, Park YH, Liong MT (2019) Lactobacillus plantarum DR7 improved upper respiratory tract infections via enhancing immune and inflammatory parameters: a randomized, double-blind, placebo-controlled study

The findings are encouraging: Over 70% of patients who discontinued GLP-1 therapy maintained at least a 5% reduction in body weight after 12 months, and more than half maintained a loss of at least 10%